(Q48933060)

16 February 2018

title

A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group. (English)

1 reference

16 February 2018

0 references

T Hedner

1

1 reference

16 February 2018

T Thulin

series ordinal

2

1 reference

16 February 2018

S Gustafsson

series ordinal

3

1 reference

16 February 2018

S O Olsson

series ordinal

4

1 reference

16 February 2018

publication date

1 January 1990

1 reference

16 February 2018

European Journal of Clinical Pharmacology

published in

1 reference

16 February 2018

volume

39

1 reference

16 February 2018

issue

5

1 reference

16 February 2018

page(s)

427-433

1 reference

16 February 2018

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

cites work

1 reference

12 December 2020

Statistics and ethics in medical research: III How large a sample?

1 reference

12 December 2020

The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Effects of diltiazem alone and combined with mefruside on cardiovascular response at rest and during exercise, carbohydrate metabolism and serum lipoproteins in patients with systemic hypertension

1 reference

12 December 2020

Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity

1 reference

12 December 2020

Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk

1 reference

12 December 2020

Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension

1 reference

12 December 2020

Effects of a low-sodium diet on antihypertensive and natriuretic responses to acute administration of nifedipine

1 reference

12 December 2020

Renal hemodynamic effects of calcium antagonists

1 reference

12 December 2020

Comparison of diltiazem and atenolol in young, physically active men with essential hypertension

1 reference

12 December 2020

Epidemiology of coronary heart disease: the Framingham study.

1 reference

12 December 2020

Sample size for short-term trials of antihypertensive drugs

1 reference

12 December 2020

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders

1 reference

12 December 2020

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse

1 reference

12 December 2020

Effect of alpha- and beta-blocker therapy on blood lipids: European experience

1 reference

12 December 2020

Calcium channel blockers: spectrum of side effects and drug interactions

1 reference

12 December 2020

Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial

1 reference

12 December 2020

Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

1 reference

12 December 2020

Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol

1 reference

12 December 2020

Diltiazem-induced left ventricular mass regression in hypertensive patients

1 reference

12 December 2020

Hemodynamic and counterregulatory effects of calcium antagonists in hypertension

1 reference

12 December 2020

Age, race, blood pressure and renin: predictors for antihypertensive treatment with calcium antagonists.

1 reference

12 December 2020

Diltiazem in hypertensive patients with type II diabetes mellitus.

1 reference

12 December 2020

Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.

1 reference

12 December 2020

Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review.

1 reference

12 December 2020

Antihypertensive and metabolic effects of diltiazem and nifedipine

1 reference

12 December 2020

Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial

1 reference

12 December 2020

Calcium antagonism and calcium entry blockade

1 reference

12 December 2020

Diltiazem. A review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol

1 reference

12 December 2020

Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension

1 reference

12 December 2020

Comparative pharmacology of 1,4-dihydropyridines and other Ca2+ channel ligands.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00280931

1 reference

16 February 2018

1 reference

16 February 2018